International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical MedicineDear IFAPP members,
We are pleased to announce a significant collaboration between IFAPP and the GMDP Academy (gmdpacademy.org), which has been formalised through a Memorandum of Understanding (MoU) recently signed by both parties.
This partnership is designed to expand educational and professional development opportunities for IFAPP members worldwide, thereby reinforcing our shared mission to promote the advancement of pharmaceutical medicine and medicines development as respected biomedical professions.
Opportunities for IFAPP members:
Through this collaboration, IFAPP members will gain access to a range of GMDP Academy programmes, including:
- Certification in the Medicines Development Programme (in collaboration with King’s College London)
- Digital Technology in Medicines Development
- Leadership in Medicines Development
Global Fellows Programmes recognise individuals who have made significant contributions to the discipline.
These programmes are jointly endorsed and promoted by IFAPP and the GMDP Academy, ensuring their alignment with IFAPP’s professional standards and values.
Special benefits for IFAPP members:
- 10% tuition discount for IFAPP members who are referred directly by IFAPP.
Roles and engagement:
IFAPP will disseminate information about GMDP Academy courses to National Member Associations (NMAs) and Individual Affiliates (IAs). Interested members will be invited to apply through IFAPP’s referral process. IFAPP will maintain records of member registrations for logistical coordination.
Next steps:
We encourage all IFAPP members to explore these opportunities and take advantage of the special benefits available. Details of upcoming courses and enrolment procedures are found under this link: GMDP Academy programmes
If you select a programme to attend, please inform Anna Jurczynska, IFAPP Secretary (anna.jurczynska@ifapp.org) so that IFAPP can approve the reduced fee and subscribe you to GMDP.
When submitting your registration to IFAPP, please indicate your country and whether you are a member of a NMA or an AI.
This collaboration represents a significant step forward in strengthening our global community of biomedical scientists, pharmaceutical physicians, and medicine development professionals, as well as other scientists. Together, we aim to foster excellence, ethical conduct and professional autonomy in the interests of patients and society.
On behalf of IFAPP
Anna Jurczynska,
IFAPP BoO Secretary, anna.jurczynska@ifapp.org
